Monday, August 29, 2022 8:50:38 PM
I will always continue to monitor "the real facts on the ground", not baseless opinions on message boards or other social media platforms. to continually update and tweak my NWBO investment strategies and decisions on an ongoing basis. I will make whatever changes I need to make to my strategy based on the current facts as we move forward through time.
I was, and I am still hopeful that NWBio will use the FDA's Project Orbis program to be able to have almost simultaneous submissions of the DCVax-L BLA / MAA packages to all relevant Project Orbis participating countries (US, Canada, UK, Switzerland and Israel).
However, no one knows for sure, but maybe NWBio knows. Most on this board believe that the UK will approve DCVax-L first. For me, I still believe Project Orbis would be the fastest and most efficient pathway. But, as I have said before, I will not be too disappointed if the UK approves first, then the other countries (US, Canada, Germany and the rest of the EU) follow with approvals in short order.
I said that NWBio should focus on the ROW approvals after DCVax-L is approved in the US, Canada, UK, Germany and the rest of the EU. That is simply the natural order of how DCVax-L approvals should progress.
Also, I am like Dr. Liau, and Dr. Ashkan, I want DCVax-L available to treat all GBM patients worldwide. Also, I am like Dr. Pazdur, if there is a new safe and effective treatment, that extends overall survival (OS) for a large percentage of patients, and is an effective cure for some patients, then that new treatment should become the new global standard of care (SOC) for all future GBM clinical trials worldwide.
In my opinion, especially if NWBio has a significant large pharmaceutical partner, multiple concurrent clinical trials for both DCVax-L and DCVax Direct will be conducted at the same time, to obtain regulatory approvals to treat all or most solid tumor cancers, both operable and inoperable.
I believe all of these future DCVax trials will be completed much faster, and NWBio will have access to a lot more additional resources, including access to cash to fund these future trials.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM